We have developed a series of genetically engineered mouse models of SCLC, in which conditional deletion of the tumor suppressor genes p53 and Rb1 in pulmonary epithelial cells triggers initiation of tumors that mirror the histology, molecular features, genetic alterations, and metastatic potential of human SCLC. Here, TP53 is linked to small cell lung carcinoma.